$LSCC
Lattice Semiconductor Corp Stock $lscc

$lscc Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000143774924013962 Filed on April 30, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q2
Revenue	$124.1M	$140.8M	$184.3M
YoY Change	-32.68%		22.45%
Cost Of Revenue	$39.33M	$44.61M	$55.71M
YoY Change	-29.41%		11.98%
Gross Profit	$84.75M	$96.21M	$128.6M
YoY Change	-34.1%		27.62%
Gross Profit Margin	68.31%	68.32%	69.77%
Selling, General & Admin	$20.01M	$36.47M	$32.58M
YoY Change	-38.59%		13.23%
% of Gross Profit	23.6%	37.91%	25.33%
Research & Development	$38.73M	$40.33M	$35.99M
YoY Change	7.62%		10.55%
% of Gross Profit	45.7%	41.91%	27.99%
Depreciation & Amortization	$9.256M	$9.129M	$8.090M
YoY Change	14.41%		12.69%
% of Gross Profit	10.92%	9.49%	6.29%
Operating Expenses	$62.19M	$77.93M	$69.47M
YoY Change	-10.48%		10.26%
Operating Profit	$22.57M	$18.28M	$59.13M
YoY Change	-61.84%		56.59%
Interest Expense	$933.0K	$1.307M	$555.0K
YoY Change	68.11%		-21.61%
% of Operating Profit	4.13%	7.15%	0.94%
Other Income/Expense, Net	$254.0K	-$46.00K	-$95.00K
YoY Change	-367.37%		331.82%
Pretax Income	$23.75M	$17.84M	$58.48M
YoY Change	-59.39%		57.92%
Income Tax	$1.100M	$3.039M	$2.600M
% Of Pretax Income	4.63%	17.04%	4.45%
Net Earnings	$22.63M	$14.80M	$55.92M
YoY Change	-59.53%		55.01%
Net Earnings / Revenue	18.24%	10.51%	30.34%
Basic Earnings Per Share	$0.16	$0.11	$0.41
Diluted Earnings Per Share	$0.16	$0.11	$0.40
COMMON SHARES
Basic Shares Outstanding	137.5M	137.6M	137.4M
Diluted Shares Outstanding	138.2M	138.8M	140.1M

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$109.2M	$107.5M	$112.1M
YoY Change	-2.6%		-8.82%
Cash & Equivalents	$109.2M	$107.5M	$112.1M
Short-Term Investments
Other Short-Term Assets	$38.99M	$24.23M	$21.83M
YoY Change	78.63%		31.67%
Inventory	$101.6M	$95.38M	$117.1M
Prepaid Expenses
Receivables	$103.4M	$113.7M	$90.82M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$353.2M	$340.7M	$348.9M
YoY Change	1.24%		16.61%
LONG-TERM ASSETS
Property, Plant & Equipment	$50.80M	$68.43M	$51.09M
YoY Change	-0.56%		28.92%
Goodwill	$315.4M	$315.4M	$315.4M
YoY Change	0.0%		0.0%
Intangibles	$19.02M	$19.89M	$23.93M
YoY Change	-20.53%		-15.59%
Long-Term Investments
YoY Change
Other Assets	$14.49M	$71.19M	$12.32M
YoY Change	17.57%		-23.13%
Total Long-Term Assets	$474.3M	$474.9M	$418.7M
YoY Change	13.27%		-0.71%
TOTAL ASSETS
Total Short-Term Assets	$353.2M	$340.7M	$348.9M
Total Long-Term Assets	$474.3M	$474.9M	$418.7M
Total Assets	$827.5M	$815.6M	$767.6M
YoY Change	7.8%		6.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$34.96M	$33.07M	$40.84M
YoY Change	-14.41%		6.11%
Accrued Expenses	$32.09M	$42.00M	$40.66M
YoY Change	-21.08%		50.25%
Deferred Revenue	$5.951M	$6.491M	$6.065M
YoY Change	-1.88%		27.95%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$80.28M	$81.56M	$97.16M
YoY Change	-17.37%		-1.92%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$103.8M
YoY Change	-100.0%		-23.92%
Other Long-Term Liabilities	$36.41M	$51.38M	$39.67M
YoY Change	-8.2%		-13.98%
Total Long-Term Liabilities	$36.41M	$51.38M	$143.5M
YoY Change	-74.62%		-21.41%
TOTAL LIABILITIES
Total Short-Term Liabilities	$80.28M	$81.56M	$97.16M
Total Long-Term Liabilities	$36.41M	$51.38M	$143.5M
Total Liabilities	$128.7M	$132.9M	$252.7M
YoY Change	-49.07%		-15.6%
SHAREHOLDERS EQUITY
Retained Earnings	$185.4M	$162.8M	-$55.17M
YoY Change	-436.04%		-78.27%
Common Stock	$1.378M	$1.375M	$1.376M
YoY Change	0.15%		0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$698.8M	$682.7M	$515.0M
YoY Change
Total Liabilities & Shareholders Equity	$827.5M	$815.6M	$767.6M
YoY Change	7.8%		6.48%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q2
OPERATING ACTIVITIES
Net Income	$22.63M	$14.80M	$55.92M
YoY Change	-59.53%		55.01%
Depreciation, Depletion And Amortization	$9.256M	$9.129M	$8.090M
YoY Change	14.41%		12.69%
Cash From Operating Activities	$21.93M	$29.51M	$44.86M
YoY Change	-51.12%		3.84%
INVESTING ACTIVITIES
Capital Expenditures	$7.155M	$3.426M	$8.414M
YoY Change	-14.96%		90.1%
Acquisitions
YoY Change
Other Investing Activities	-$3.286M	-$4.321M	-$2.615M
YoY Change	25.66%		-3.29%
Cash From Investing Activities	-$10.44M	-$7.747M	-$11.03M
YoY Change	-5.33%		54.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$8.769M
YoY Change			-39.1%
Debt Paid & Issued, Net		$0.00	$25.00M
YoY Change			471.43%
Cash From Financing Activities	-9.559M	-42.17M	-$67.56M
YoY Change	-85.85%		52.14%
NET CHANGE
Cash From Operating Activities	21.93M	29.51M	$44.86M
Cash From Investing Activities	-10.44M	-7.747M	-$11.03M
Cash From Financing Activities	-9.559M	-42.17M	-$67.56M
Net Change In Cash	1.931M	-20.41M	-$33.59M
YoY Change	-105.75%		291.4%
FREE CASH FLOW
Cash From Operating Activities	$21.93M	$29.51M	$44.86M
Capital Expenditures	$7.155M	$3.426M	$8.414M
Free Cash Flow	$14.78M	$26.09M	$36.45M
YoY Change	-59.46%		-6.01%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-28
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	115560000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	125856000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	137538000
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	137538000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	137340000
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	137340000
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-30
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	000-18032
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	93-0835214
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	5555 NE Moore Court
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Hillsboro
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	OR
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	97124
CY2024Q1	dei	City Area Code CityAreaCode	503
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	268-8000
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, $.01 par value
CY2024Q1	dei	Trading Symbol TradingSymbol	LSCC
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	137546399
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	140815000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	184310000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	44607000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	55709000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	96208000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	128601000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	40591000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	35989000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	36469000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	32578000	usd
CY2024Q1	lscc	Amortization Of Intangible Assets Acquired AmortizationOfIntangibleAssetsAcquired	870000	usd
CY2023Q2	lscc	Amortization Of Intangible Assets Acquired AmortizationOfIntangibleAssetsAcquired	870000	usd
CY2024Q1	us-gaap	Restructuring Charges RestructuringCharges	1704000	usd
CY2023Q2	us-gaap	Restructuring Charges RestructuringCharges	30000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	79634000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	69467000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	16574000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	59134000	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1307000	usd
CY2023Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-555000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-46000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-95000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	17835000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	58484000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3039000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2561000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	14796000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	55923000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.41
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.4
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	137475000
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	137418000
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	138774000
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	140101000
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	14796000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	55923000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-474000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	189000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	14322000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	56112000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	107466000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	128317000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	98940000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	104373000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	95384000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	98826000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	38948000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	36430000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	340738000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	367946000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	51390000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	49546000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	17039000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14487000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	19888000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	20974000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	315358000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	315358000	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	57111000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	57762000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	14075000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	14821000	usd
CY2024Q1	us-gaap	Assets Assets	815599000	usd
CY2023Q4	us-gaap	Assets Assets	840894000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	33069000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	34487000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	32049000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	36048000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	16443000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	26865000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	81561000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	97400000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	12799000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	10739000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	38577000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	40735000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	132937000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	148874000	usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	1375000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1373000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	521904000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	545586000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	162763000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	147967000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3380000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2906000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	682662000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	692020000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	815599000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	840894000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	14796000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	55923000	usd
CY2024Q1	lscc	Depreciation Depletion And Amortization Excluding Right Of Use Asset And Finance Costs DepreciationDepletionAndAmortizationExcludingRightOfUseAssetAndFinanceCosts	9129000	usd
CY2023Q2	lscc	Depreciation Depletion And Amortization Excluding Right Of Use Asset And Finance Costs DepreciationDepletionAndAmortizationExcludingRightOfUseAssetAndFinanceCosts	8090000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	18494000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	14255000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	510000	usd
CY2023Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-388000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1865000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1657000	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-67000	usd
CY2023Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-45000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5433000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3196000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3442000	usd
CY2023Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6704000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3598000	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-368000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1418000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1193000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-6657000	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-7498000	usd
CY2024Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-10422000	usd
CY2023Q2	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-21216000	usd
CY2024Q1	lscc	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-2130000	usd
CY2023Q2	lscc	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-1671000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	29511000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	44864000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3426000	usd
CY2023Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8414000	usd
CY2024Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	4321000	usd
CY2023Q2	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2615000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7747000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11029000	usd
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	22719000	usd
CY2023Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	33787000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	545000	usd
CY2023Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1235000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	20000000	usd
CY2023Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	10004000	usd
CY2024Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	-0	usd
CY2023Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	25000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-42174000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-67556000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-441000	usd
CY2023Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	135000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-20851000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-33586000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	128317000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	145722000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	107466000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	112136000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023Q2	us-gaap	Interest Paid Net InterestPaidNet	1849000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1249000	usd
CY2023Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	413000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	2099000	usd
CY2023Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	2000000	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3361000	usd
CY2023Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	399000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4684000	usd
CY2023Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	40000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	692020000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	14796000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-474000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	14322000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-22174000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18494000	usd
CY2024Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	20000000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	682662000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	487163000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	55923000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	189000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	56112000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-32552000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14255000	usd
CY2023Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	10004000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	514974000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: Arial; font-size: 9pt; margin: 0pt; text-align: left;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments affecting the amounts reported in our consolidated condensed financial statements and the accompanying notes. We base our estimates and judgments on historical experience, knowledge of current conditions, and our beliefs of what could occur in the future considering available information. While we believe that our estimates, assumptions, and judgments are reasonable, they are based on information available when made, and because of the uncertainty inherent in these matters, the actual results that we experience <em style="font: inherit;"> may </em>differ materially from these estimates under different assumptions or conditions. We evaluate our estimates and judgments on an ongoing basis.</p> <p style="font-family: Arial; font-size: 9pt; margin: 0pt; text-align: left;"> </p> <p style="font-family: Arial; font-size: 9pt; margin: 0pt; text-align: left;">We describe our accounting methods and practices in more detail in our <em style="font: inherit;">2023</em> <em style="font: inherit;">10</em>-K. There have been <em style="font: inherit;">no</em> changes to the significant accounting policies, procedures, or general information described in our <em style="font: inherit;">2023</em> <em style="font: inherit;">10</em>-K that have had a material impact on our consolidated financial statements and related notes. <span style="background-color:#ffffff;">Certain prior year balances have been reclassified to conform to the current year’s presentation.</span></p> <p style="font-family:'Arial', Arial, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family: Arial; font-size: 10pt; margin: 0pt; text-align: left;"></p>
CY2024Q1	us-gaap	Fiscal Period FiscalPeriod	<p style="font-family: Arial; font-size: 10pt; margin: 0pt; text-align: left;"><b>Fiscal Reporting Periods</b></p> <p style="font-family:'Arial', Arial, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family: Arial; font-size: 9pt; margin: 0pt; text-align: left;">We report based on a <em style="font: inherit;">52</em> or <em style="font: inherit;">53</em>-week fiscal year ending on the Saturday closest to <em style="font: inherit;"> December 31. </em>Our fiscal <em style="font: inherit;">2024</em> will be a <em style="font: inherit;">52</em>-week year and will end on <em style="font: inherit;"> December 28, 2024, </em>and our fiscal <em style="font: inherit;">2023</em> was a <em style="font: inherit;">52</em>-week year that ended <em style="font: inherit;"> December 30, 2023. </em>Our <em style="font: inherit;">first</em> quarter of fiscal <em style="font: inherit;">2024</em> and <em style="font: inherit;">first</em> quarter of fiscal <em style="font: inherit;">2023</em> ended on <em style="font: inherit;"> March 30, 2024 </em>and <em style="font: inherit;"> April 1, 2023</em>, respectively. All references to quarterly financial results are references to the results for the relevant <em style="font: inherit;">13</em>-week fiscal period.</p> <p style="font-family: Arial; font-size: 9pt; margin: 0pt; text-align: left;"> </p> <p style="font-family:'Arial', Arial, serif;font-size:10pt;margin:0pt;text-align:left;"></p>
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Arial', Arial, serif;font-size:10pt;margin:0pt;text-align:left;"><b>Concentrations of Risk</b></p> <p style="font-family:'Arial', Arial, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family: Arial; font-size: 9pt; margin: 0pt; text-align: left;">Potential exposure to concentrations of risk <em style="font: inherit;"> may </em>impact revenue and accounts receivable. Distributors have historically accounted for a significant portion of our total revenue. Revenue attributable to distributors as a percentage of total revenue was <span style="background-color:#ffffff;">87% and 88%</span> for the <em style="font: inherit;">first</em> quarters of fiscal <em style="font: inherit;">2024</em> and <em style="font: inherit;">2023</em>, respectively. Distributors also account for a substantial portion of our net accounts receivable. Our <span style="-sec-ix-hidden:c111489139"><span style="-sec-ix-hidden:c111489140">three</span></span> largest distributors accounte<span style="background-color:#ffffff;">d for 42</span><span style="background-color:#ffffff;">%, 30%, and 10</span><span style="background-color:#ffffff;">% of net accounts receivable at </span><em style="font: inherit;"> March 30, 2024</em><span style="background-color:#ffffff;"> and 36%, 29%, and 18%</span> of net accounts receivable at <em style="font: inherit;"> December 30, 2023</em>.</p>
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	14796000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	55923000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	137475000
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	137418000
CY2024Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1299000
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2683000
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	138774000
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	140101000
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.41
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.4
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	950000
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	141000
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	140815000	usd
CY2024Q1	lscc	Percentage Of Revenue PercentageOfRevenue	1	pure
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	184310000	usd
CY2023Q2	lscc	Percentage Of Revenue PercentageOfRevenue	1	pure
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	140815000	usd
CY2024Q1	lscc	Percentage Of Revenue PercentageOfRevenue	1	pure
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	184310000	usd
CY2023Q2	lscc	Percentage Of Revenue PercentageOfRevenue	1	pure
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	11194000	usd
CY2024Q1	lscc	Contract With Customer Asset Revenue Recorded During Period ContractWithCustomerAssetRevenueRecordedDuringPeriod	3947000	usd
CY2024Q1	us-gaap	Contract With Customer Asset Reclassified To Receivable ContractWithCustomerAssetReclassifiedToReceivable	418000	usd
CY2024Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	14723000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	5304000	usd
CY2024Q1	lscc	Contract With Customer Liability Accrued For Estimated Future Stock Rotation And Scrap Returns ContractWithCustomerLiabilityAccruedForEstimatedFutureStockRotationAndScrapReturns	4551000	usd
CY2024Q1	lscc	Contract With Customer Liability Release Of Accruals For Recognized Stock Rotation And Scrap Returns ContractWithCustomerLiabilityReleaseOfAccrualsForRecognizedStockRotationAndScrapReturns	3364000	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	6491000	usd
CY2024Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	98940000	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	104373000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	-0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	-0	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	98940000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	104373000	usd
CY2024Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	67605000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	65396000	usd
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	27779000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	33430000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	95384000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	98826000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	51390000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	49546000	usd
CY2024Q1	lscc	Liability For Noncancelable Contracts Current LiabilityForNoncancelableContractsCurrent	10520000	usd
CY2023Q4	lscc	Liability For Noncancelable Contracts Current LiabilityForNoncancelableContractsCurrent	11418000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	6491000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5304000	usd
CY2024Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	4809000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	6758000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4164000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6997000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	32049000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	36048000	usd
CY2024Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	0	usd
CY2023Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1785000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	67000	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	67000	usd
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	67000	usd
CY2023Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	1852000	usd
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	6618000	usd
CY2024Q1	us-gaap	Restructuring Charges RestructuringCharges	1704000	usd
CY2024Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	3333000	usd
CY2024Q1	us-gaap	Restructuring Reserve RestructuringReserve	4989000	usd
CY2022Q4	us-gaap	Restructuring Reserve RestructuringReserve	6932000	usd
CY2023Q2	us-gaap	Restructuring Charges RestructuringCharges	30000	usd
CY2023Q2	us-gaap	Payments For Restructuring PaymentsForRestructuring	472000	usd
CY2023Q2	us-gaap	Restructuring Reserve RestructuringReserve	6490000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y7M6D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.06	pure
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	2100000	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	1900000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	144900000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14487000	usd
CY2024Q1	lscc	Rightofuse Assets Obtained For New And Modified Lease Contracts During The Period RightofuseAssetsObtainedForNewAndModifiedLeaseContractsDuringThePeriod	4684000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1865000	usd
CY2024Q1	lscc	Operating Lease Rightofuse Asset Adjustments For Present Value And Foreign Currency Effects OperatingLeaseRightofuseAssetAdjustmentsForPresentValueAndForeignCurrencyEffects	-267000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	17039000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	16310000	usd
CY2024Q1	lscc	Operating Lease Liability Additions OperatingLeaseLiabilityAdditions	4684000	usd
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	268000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	2099000	usd
CY2024Q1	lscc	Operating Lease Liabilities Adjustments For Present Value Foreign Currency And Restructuring Liability Effects OperatingLeaseLiabilitiesAdjustmentsForPresentValueForeignCurrencyAndRestructuringLiabilityEffects	-299000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	18864000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	12799000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	5114000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	6098000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4492000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2783000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2232000	usd
CY2024Q1	lscc	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	447000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	21166000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2302000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	18864000	usd
CY2024Q1	lscc	Operating Lease Liability For Previously Restructured Facilities OperatingLeaseLiabilityForPreviouslyRestructuredFacilities	4100000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	146000000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1136000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1140000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18494000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14255000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3000000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2600000	usd
CY2024Q1	us-gaap	Decrease In Unrecognized Tax Benefits Is Reasonably Possible DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	36000000	usd
CY2024Q1	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<p style="font-family: Arial; font-size: 11pt; margin: 0pt; text-align: left;"><b><a href="#" id="note12" title="note12"></a>Note <em style="font: inherit;">12</em> - Contingencies</b></p> <p style="font-family:'Arial', Arial, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family: Arial; font-size: 10pt; margin: 0pt; text-align: left;"><b>Legal Proceedings</b></p> <p style="font-family:'Arial', Arial, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family: Arial; font-size: 9pt; margin: 0pt; text-align: left;">On or about <em style="font: inherit;"> December 19, 2018, </em>Steven De Jaray, Perienne De Jaray and Darrell Oswald (collectively, the “Plaintiffs”) commenced an action against the Company in the Multnomah County Circuit Court of the State of Oregon, in connection with the sale of certain products by the Company to the Plaintiffs in or around <em style="font: inherit;">2008.</em> The Plaintiffs alleged the Company violated the Lanham Act, engaged in negligence, fraud, and breach of contract by failing to disclose to the Plaintiffs the export-controlled status of the subject parts. In <em style="font: inherit;"> January 2019, </em>we removed the action to the United States District Court for the District of Oregon (the “Court”). On <em style="font: inherit;"> May 24, 2023, </em>the Plaintiffs filed a <em style="font: inherit;">second</em> amended complaint, which added Apex-Micro Manufacturing Corporation (“Apex-Micro”) as a plaintiff and removed the violation of the Lanham Act claim. The Plaintiffs sought damages of $180 million, punitive damages, and other remedies. On <em style="font: inherit;"> January 18, 2024, </em>the court dismissed the claims against the Company by Ms. De Jaray and Mr. Oswald. The trial for the remaining claims was held from <em style="font: inherit;"> January 30, 2024 </em>to <em style="font: inherit;"> February 15, 2024. </em>On <em style="font: inherit;"> February 13, 2024, </em>the Court granted the Company’s Rule <em style="font: inherit;">50</em> motion in part and entered judgment in the Company’s favor as to all of Mr. De Jaray’s claims and Apex-Micro’s negligence claims. On <em style="font: inherit;"> February 15, 2024, </em>the jury found that the Company was <em style="font: inherit;">not</em> liable for all outstanding claims and judgment was entered in favor of the Company. On <em style="font: inherit;"> March 15, 2024, </em>Mr. De Jaray and Apex-Micro filed a Notice of Appeal to the United States Court of Appeals for the Ninth Circuit. On <em style="font: inherit;"> March 18, 2024, </em>Ms. De Jaray filed a separate Notice of Appeal . The plaintiffs’ appeal opening brief is currently due <em style="font: inherit;"> June 10, 2024. </em>The Company will file an appeal answering brief.</p> <p style="font-family: Arial; font-size: 9pt; margin: 0pt; text-align: left;"> </p> <p style="font-family: Arial; font-size: 9pt; margin: 0pt; text-align: left;">From time to time, we are exposed to certain additional asserted and unasserted potential claims. We review the status of each significant matter and assess its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and a range of possible losses can be estimated, we then accrue a liability for the estimated loss. Legal proceedings are subject to uncertainties, and the outcomes are difficult to predict. Because of such uncertainties, accruals are based only on the best information available at the time. As additional information becomes available, we reassess the potential liability related to pending claims and litigation and <em style="font: inherit;"> may </em>revise estimates.</p>

Files In Submission

Name	View Source	Status
0001437749-24-013962-index-headers.html	Edgar Link	pending
0001437749-24-013962-index.html	Edgar Link	pending
0001437749-24-013962.txt	Edgar Link	pending
0001437749-24-013962-xbrl.zip	Edgar Link	pending
ex_632928.htm	Edgar Link	pending
ex_632929.htm	Edgar Link	pending
ex_632930.htm	Edgar Link	pending
ex_632931.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
latticelogocolorpmsa49.jpg	Edgar Link	pending
lscc-20240330.xsd	Edgar Link	pending
lscc20240330_10q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
lscc-20240330_cal.xml	Edgar Link	unprocessable
lscc-20240330_def.xml	Edgar Link	unprocessable
lscc20240330_10q_htm.xml	Edgar Link	completed
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
lscc-20240330_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
lscc-20240330_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LSCC
Lattice Semiconductor Corp Stock $lscc

2024 Q2 Form 10-Q Financial Statement

#000143774924013962 Filed on April 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LSCC Lattice Semiconductor Corp Stock $lscc

2024 Q2 Form 10-Q Financial Statement

#000143774924013962 Filed on April 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LSCC
Lattice Semiconductor Corp Stock $lscc